Mechanisms of hypersensitivity to intravenous agents.
D000530:Alfaxalone Alfadolone Mixture / Q000009:adverse effects; D000707:Anaphylaxis / Q000139:chemically induced; D000777:Anesthetics / Q000008:administration & dosage / Q000009:adverse effects*; D000818:Animals; D002415:Cats; D004285:Dogs; D004342:Drug Hypersensitivity / Q000662:veterinary; D006801:Humans; D007275:Injections, Intravenous; D010952:Plasma Substitutes / Q000008:administration & dosage / Q000009:adverse effects*; D011092:Polyethylene Glycols / Q000009:adverse effects; D013045:Species Specificity; D013874:Thiopental / Q000009:adverse effects
D000777:Anesthetics; D010952:Plasma Substitutes; C022131:cremophor; D011092:Polyethylene Glycols; D000530:Alfaxalone Alfadolone Mixture; D013874:Thiopental